{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2092, 
        2103
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1190, 
        1204
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1514, 
        1523
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1552, 
        1566
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1832, 
        1846
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2049, 
        2063
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2104, 
        2113
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1404, 
        1431
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1744, 
        1769
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        556, 
        585
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        843, 
        869
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        890, 
        909
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2030, 
        2038
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1180, 
        1189
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1433, 
        1448
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1542, 
        1551
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1822, 
        1831
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2039, 
        2048
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2121, 
        2129
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9999^MOH|PIMS|CCO|201605022311|154F70583D500CD6001C9EECECCFB49A62EA85FD|ORU^R01|999999999999999|P|2.5|\nPID|1||M99999999^^^^CMR^HOSPITAL 11&9999&MOH~~M99999999^^^^MRN^HOSPITAL HOSPITAL&9999&MOH~9999999999&EX&ON^^^^JHN|9999^M99999999|XXXXXX^XXXX^XXXXXXX||99999999|M|||9 XXXXXX XXX^^XXXXXXXXXXX^XX^X9X 9X9^999||999-999-9999|||||||||||||||||N|\nOBR|1||16:S3550|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160404|||52485^XXXXXXXXXX^XXXXXXXX||||||||||||20160428|||C|||||||99999^XXXXXXXXXX XXXXXXX^XXXXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen is labelled \"prostate tissues\" and consists of multiple tan-gray,\nrubbery and cauterized tissue fragments that weigh 1.4 grams and measures 3.5 cm\nx 2.0 cm x 0.5 cm in aggregate.\nThe specimen is entirely submitted in Blocks A1 and A2.\nLF/sk\n\n\nPath report.site of origin\n\nProstate tissues\n\n\nPath report.comment\n\nIt is difficult to definitely classify the infiltrating high-grade carcinoma\nbased on histology alone, as it consists predominantly of large tumour nests,\nsome with central comedo necrosis. Given the clinical history and some of the\nhistological features, a high-grade prostatic adenocarcinoma is suspected.\nHowever, immunohistochemistry is pending for definitive classification (to rule\nout high-grade urothelial carcinoma), and to better assess the possibility of\nlymph-vascular invasion.\n\n\nPath report.final diagnosis\n\nPROSTATE TISSUE, TRANSURETHRAL RESECTION:\n - PROMINENT INVOLVEMENT BY HIGH-GRADE CARCINOMA\n  (SUSPICIOUS FOR PROSTATIC ADENOCARCINOMA, GLEASON PATTERN 5).\n - PERINEURAL INVASION PRESENT.\n - SUSPICIOUS FOR LYMPH-VASCULAR INVASION\nDEFINITIVE CHARACTERIZATION BY IMMUNOHISTOCHEMISTRY TO BE REPORTED IN ADDENDUM.\n\n\nPath report.addendum spec\n\nThe immunohistochemical profile is consistent with prostatic adenocarcinoma\n(strongly PSA positive; negative for high-molecular weight cytokeratin (HMW\nCK), for cytokeratin 7 and cytokeratin 20). Focal lymph-vascular invasion is\nconfirmed. In addition to the invasive prostatic adenocarcinoma, a few foci\nconsistent with intraductal carcinoma of the prostate (IDC-P) are identified by\nimmunohistochemistry for HMW CK. As noted in the Diagnosis section of the\nreport, the tumour shows a predominant Gleason grade 5 pattern in this TURP\nspecimen.\n\n\n"
}